Skip to main content
CBIO logo

CBIO

Crescent Biopharma, Inc.
$17.09 +0.01 (+0.06%) At close · Jul 2
Market Cap
$471.25M
Shares
27,571,935

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 60
Total Value: $482,647,729
Total Shares: 26,273,694

Institutional Ownership Trend

4 quarters

Holder Concentration

Across 60 13F filers · Δ vs Dec 31, 2025
Top Holder
16.5%
Jun 2025 → Mar 2026 · range 12.5% – 17.4%
−1.0 pts
Top 5
53.5%
Jun 2025 → Mar 2026 · range 53.5% – 57.9%
−3.1 pts
Top 10
78.5%
Jun 2025 → Mar 2026 · range 76.7% – 79.9%
+1.9 pts
HHI
780
Jun 2025 → Mar 2026 · range 780 – 863
Broadly held−44

Quarterly Activity

vs Dec 31, 2025
New
17
Increased
17
Decreased
8
Sold Out
13
Unchanged
18
Holder count: +4
Institutional value: +71.4%
Shares held: +10.7%

Top Buyers

vs Dec 31, 2025
Institution Added Now Holds Open

Top Sellers

vs Dec 31, 2025
Institution Sold Now Holds Open

Top New Positions

vs Dec 31, 2025
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Dec 31, 2025
Institution Previously Held Last Value (USD) Open
Showing 61 of 61
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1253689 CUSIP G2545C104 Visit website Investor relations